San Jose, CA, United States of America

Trevor T Charvat

USPTO Granted Patents = 22 


 

Average Co-Inventor Count = 10.8

ph-index = 6

Forward Citations = 208(Granted Patents)


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovator Profile: Trevor T. Charvat

Introduction: Trevor T. Charvat, based in San Jose, California, is a prolific inventor with an impressive portfolio of 22 patents. His contributions to the field of pharmaceutical sciences highlight his innovative approach to developing compounds targeting critical disease mechanisms.

Latest Patents: Among his latest patents, Charvat has made significant strides in the development of substituted anilines as CCR4 antagonists. These aniline compounds exhibit binding affinity to the CCR4 receptor and are positioned as potential therapeutic agents for a variety of conditions, including allergic and autoimmune diseases, as well as cancer. In addition, he has worked on heteroaryl sulfonamides and their role as antagonists of the CCR2 receptor. Animal testing has shown these compounds to be effective in treating inflammation, which is a key characteristic of CCR2-mediated diseases. These aryl sulfonamide derivatives are anticipated to play a crucial role in pharmaceutical compositions and methods designed for CCR2-related therapeutic applications.

Career Highlights: Charvat's career includes his current role at ChemoCentryx, Inc., a company dedicated to developing innovative therapeutics for severe diseases. His efforts to enhance the understanding and treatment of rare and complex conditions have established him as a significant figure in the biopharmaceutical sector.

Collaborations: Throughout his career, Charvat has collaborated with esteemed colleagues such as Sreenivas Punna and Solomon Ungashe. Their combined expertise has driven forward the innovative work at ChemoCentryx and contributed to advancing the field of targeted therapy.

Conclusion: Trevor T. Charvat's endeavors in pharmaceutical innovation demonstrate his commitment to addressing critical health challenges. His extensive patent portfolio not only underscores his inventive capabilities but also reflects the impact his work is likely to have on future therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…